Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals

被引:25
|
作者
Shafer, RW [1 ]
Warford, A [1 ]
Winters, MA [1 ]
Gonzales, MJ [1 ]
机构
[1] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
关键词
HIV-1; protease; reverse transcriptase;
D O I
10.1016/S0166-0934(00)00144-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The reproducibility of population-based human immunodeficiency virus type 1 (HIV-I) protease and reverse transcriptase (RT) sequencing was assessed using replicate aliquots of cryopreserved plasma samples obtained from seven heavily treated HIV-1-infected individuals. The sequence of each sample replicate was compared with the consensus sequence for that sample and 99.4% of 35128 amino acids were found to be concordant with the sample consensus. Partial discordances were present at 0.5% of positions and complete discordances were present at <0.1% of positions. To assess the reproducibility at detecting mutations (defined here as differences from the subtype B consensus sequence), the proportion of sequences having a mutation when at least two sequences from that sample had the same mutation were examined. There was a median of 13 protease and 18 RT mutations per sample for a total of 3126 mutations; 95% of these mutations were detected. However, sequencing of multiple clones from two samples demonstrated that those mutations present in a minority of clones were often not detected by population-based sequencing. These results suggest that HIV-I protease and RT sequencing of circulating plasma virus is highly reproducible but that the sensitivity at detecting mutations may be low if those mutations are present as minor variants. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 153
页数:11
相关论文
共 50 条
  • [31] Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients
    Shafer, RW
    Winters, MA
    Palmer, S
    Merigan, TC
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (11) : 906 - 911
  • [32] LOCALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRUCTURAL PROTEINS IN HIV-1-INFECTED CELLS AND ITS DIAGNOSTIC APPLICATION
    GOTO, T
    NAKAI, M
    JOURNAL OF ELECTRON MICROSCOPY, 1990, 39 (03): : 199 - 199
  • [33] Eradication of Human Immunodeficiency Virus Type-1 (HIV-1)-Infected Cells
    Duzgunes, Nejat
    Konopka, Krystyna
    PHARMACEUTICS, 2019, 11 (06)
  • [34] HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
    Rhee, Soo-Yon
    Sankaran, Kris
    Varghese, Vici
    Winters, Mark A.
    Hurt, Christopher B.
    Eron, Joseph J.
    Parkin, Neil
    Holmes, Susan P.
    Holodniy, Mark
    Shafer, Robert W.
    JOURNAL OF VIROLOGY, 2016, 90 (13) : 6058 - 6070
  • [35] Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIV
    Balzarini, J
    Camarasa, MJ
    Pérez-Pérez, MJ
    San-Fléix, A
    Velázquez, S
    Perno, CF
    De Clercq, E
    Anderson, JN
    Karlsson, A
    JOURNAL OF VIROLOGY, 2001, 75 (13) : 5772 - 5777
  • [36] Clinical and Resistance Consequences of Misquantification of Plasma and Cerebrospinal Fluid Human Immunodeficiency Virus Type 1 (HIV-1) RNA in Samples from an HIV-1 Subtype G-Infected Patient
    Delaugerre, Constance
    Denis, Blandine
    Peytavin, Gilles
    Palmer, Pierre
    Mourez, Thomas
    Le Goff, Jerome
    Molina, Jean-Michel
    Simon, Francois
    JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (11) : 3763 - 3764
  • [37] PURIFICATION AND CHARACTERIZATION OF HETERODIMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE PRODUCED BY INVITRO PROCESSING OF P66 WITH RECOMBINANT HIV-1 PROTEASE
    CHATTOPADHYAY, D
    EVANS, DB
    DEIBEL, MR
    VOSTERS, AF
    ECKENRODE, FM
    EINSPAHR, HM
    HUI, JO
    TOMASSELLI, AG
    ZURCHERNEELY, HA
    HEINRIKSON, RL
    SHARMA, SK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (20) : 14227 - 14232
  • [38] HIGH PREVALENCE OF SERUM ANTIBODIES TO REVERSE-TRANSCRIPTASE IN HIV-1-INFECTED INDIVIDUALS
    DEVICO, AL
    VERONESE, FD
    LEE, SL
    GALLO, RC
    SARNGADHARAN, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (01) : 17 - 22
  • [39] Molecular Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals in a Network-Based Intervention (Transmission Reduction Intervention Project): Phylogenetics Identify HIV-1-Infected Individuals With Social Links
    Kostaki, Evangelia-Georgia
    Nikolopoulos, Georgios K.
    Pavlitina, Eirini
    Williams, Leslie
    Magiorkinis, Gkikas
    Schneider, John
    Skaathun, Britt
    Morgan, Ethan
    Psichogiou, Mina
    Daikos, Georgios L.
    Sypsa, Vana
    Smyrnov, Pavlo
    Korobchuk, Ania
    Malliori, Meni
    Hatzakis, Angelos
    Friedman, Samuel R.
    Paraskevis, Dimitrios
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (05): : 707 - 715
  • [40] Mechanism and inhibition of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) by an imidazolidine nucleotide analog.
    Kerr, SG
    Dhareshwar, SS
    Froimowitz, M
    Kalman, TI
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U174 - U175